Company Analysis

LifeMD, Inc. (LFMD)

Nasdaq: LFMD · Services-Offices & Clinics of Doctors of Medicine · New York, NY · filing with the SEC since 2012
Grade6.4
◀ Past 5.3● Present 7.1▶ Future 6.4

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

7 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to LifeMD, Inc.’s names, not what it holds today.

Patents granted
7
6 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
4
since 2001, to Dec 31, 2025
Names they are printed under
1
a former name
By yearGrantedApplications published
'90'98'00'01'06'08'09'10'11
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
Immudyne, Inc. a former name
US, as the owner printed on each patent
7 granted
4 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Aug 17, 20107,777,027Purified beta glucan compositionPharmaceuticalsImmudyne, Inc.
Jun 23, 20097,550,584Methods of purifying beta glucansPharmaceuticalsImmudyne, Inc.
Mar 28, 20067,018,986Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorptionPharmaceuticalsImmudyne, Inc.
Jan 16, 2001D436,313Package for displaying a productImmudyne, Inc.
Dec 19, 20006,162,787Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositionsPharmaceuticalsImmudyne, Inc.
Jul 28, 19985,786,343Phagocytosis activator compositions and their usePharmaceuticalsImmudyne, Inc.
Jan 2, 19904,891,220Method and composition for treating hyperlipidemiaPharmaceuticalsImmudyne, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 11, 20112011/0195926PURIFIED BETA GLUCAN COMPOSITIONPharmaceuticalsImmudyne, Inc.
Nov 4, 20102010/0279979IMMUNOPOTENTIATING AGENT FOR USE IN ANIMALSFood chemistryImmudyne, Inc.
Oct 21, 20102010/0267661BETA GLUCANS AND METHODS OF USE THEREOFPharmaceuticalsImmudyne, Inc.
Aug 21, 20082008/0200429Purified Beta Glucan CompositionPharmaceuticalsImmudyne, Inc. · patent 7,777,027 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton LFMD · research, not advice